Is MGM-15 Legal in Kentucky? (2026)

Instrument

KY Schedule I - 7-OH concentrated >400 ppm dry weight (mitragynine excluded)

Source

https://apps.legislature.ky.gov/law/kar/titles/902/055/015/

Retrieved

2026-07-07

Fingerprint

d39380804600fb46

Section 1. Schedule I Controlled Substances. (1) Each substance that is scheduled or designated as a Schedule I controlled substance under 21 C.F.R. 1308.11, including a substance temporarily scheduled ... shall be scheduled ... at the state level as a Schedule I controlled substance. (2) The Cabinet for Health and Family Services designates the following as Schedule I controlled substances: (a) tianeptine; (b) bromazolam; and (c) 7-hydroxymitragynine (7-OH) concentrated at a level above 400 parts per million on a dry weight basis. This designation does not apply to mitragynine. (3) The following shall be exempt ...: (a) Cannabis plant material ... pursuant to 21 C.F.R. 1308.35; and (b) Any substance ... exempt from the definition of marijuana pursuant to KRS 218A.010(27)(a)-(f).

Instrument

Kratom processors and retailers: prohibitions

Source

https://apps.legislature.ky.gov/law/statutes/statute.aspx?id=54825

Retrieved

2026-10-29

Fingerprint

3e297f06821237e0

217.2202   Kratom processors and retailers -- Prohibitions.      (Effective until July 1,

2027)

A kratom processor or kratom retailer shall not:
(1)  Distribute, dispense, sell, or make available for sale any kratom extract  or kratom

product to an individual who is under twenty-one (21) years of age; or

(2)  Prepare,  manufacture,  distribute,  dispense,  sell,  or  make  available  for  sale  any

kratom extract or kratom product that:
(a)

Is  adulterated  with  a  dangerous  nonkratom  substance  that  affects  the  quality
or  strength  of  the  kratom  extract  or  kratom  product  to  such  a  degree  that  it
may injure a consumer;

(b)  Contains  a  poisonous  or  otherwise  harmful  nonkratom  ingredient,  including

but not limited to any controlled substance as defined in KRS Chapter 218A;

(c)  Contains  a  level  of  7-hydroxymitragynine  in  the  alkaloid  fraction  that  is
greater  than  two  percent  (2%)  of  the  overall  alkaloid  composition  of  the
product;

(d)  Contains any synthetic alkaloid, including synthetic mitragynine, synthetic 7-
hydroxymitragynine, or any other synthetically derived compound of the plant
Mitragyna speciosa;

(e)  Contains  levels  of  residual  solvents  higher  than  those  permitted  under  the

United States Pharmacopeia Chapter 467; or

(f)  Does  not  meet  the  labeling  requirements  established  pursuant  to  KRS

217.2203 or any administrative regulation promulgated thereunder.

Effective:  July 15, 2024

History:  Created 2024 Ky. Acts ch. 44, sec. 2, effective July 15, 2024.

Instrument

Kratom processors and retailers, prohibitions; definitions; Schedule I controlled substances; controlled substance analogue

Source

https://apps.legislature.ky.gov/law/statutes/statute.aspx?id=54825

Retrieved

2026-11-08

Fingerprint

13b27997515bcee0

217.2202 Kratom processors and retailers -- Prohibitions.
2027)

(Effective until July 1,

A kratom processor or kratom retailer shall not:
(1) Distribute, dispense, sell, or make available for sale any kratom extract or kratom
product to an individual who is under twenty-one (21) years of age; or
(2) Prepare, manufacture, distribute, dispense, sell, or make available for sale any
kratom extract or kratom product that:
(a) Is adulterated with a dangerous nonkratom substance that affects the quality
or strength of the kratom extract or kratom product to such a degree that it
may injure a consumer;
(b) Contains a poisonous or otherwise harmful nonkratom ingredient, including
but not limited to any controlled substance as defined in KRS Chapter 218A;
(c) Contains a level of 7-hydroxymitragynine in the alkaloid fraction that is
greater than two percent (2%) of the overall alkaloid composition of the
product;
(d) Contains any synthetic alkaloid, including synthetic mitragynine, synthetic 7hydroxymitragynine, or any other synthetically derived compound of the plant
Mitragyna speciosa;
(e) Contains levels of residual solvents higher than those permitted under the
United States Pharmacopeia Chapter 467; or
(f) Does not meet the labeling requirements established pursuant to KRS
217.2203 or any administrative regulation promulgated thereunder.
Effective: July 15, 2024
History: Created 2024 Ky. Acts ch. 44, sec. 2, effective July 15, 2024.

217.2201 Definitions for KRS 217.2201 to 217.2209.
As used in KRS 217.2201 to 217.2209:
(1) "Department" means the Department for Public Health;
(2) "Food" has the same meaning as in KRS 217.015 and includes any beverage,
dietary ingredient, dietary supplement, or food additive as defined in KRS 217.015
intended for human consumption;
(3) "Kratom" means any part of the plant Mitragyna speciosa;
(4) "Kratom extract" means any food, food product, or dietary ingredient containing
any part of the leaf of the plant Mitragyna speciosa that has been extracted and
concentrated in order to provide more standardized dosing;
(5) “Kratom processor” means any person or entity that prepares, manufactures,
distributes, or maintains kratom extracts or kratom products or advertises,
represents, or claims to sell, prepare, or maintain kratom extracts or kratom
products;
(6) "Kratom product" means a food, powder, capsule, pill, or any other product
intended for oral consumption that contains any part of the leaf of the plant
Mitragyna speciosa or any extract thereof; and
(7) “Kratom retailer” means any person or entity that sells or advertises, represents, or
claims to sell kratom extracts or kratom products.
Effective: July 15, 2024

Each substance that is scheduled or designated as a Schedule I controlled substance under 21 C.F.R. 1308.11, including a substance temporarily scheduled or designated under 21 C.F.R. 1308.11(h) or 1308.49, shall be scheduled or designated at the state level as a Schedule I controlled substance.
(2)
The Cabinet for Health and Family Services designates the following as Schedule I controlled substances:
(a)
tianeptine;
(b)
bromazolam; and
(c)
7-hydroxymitragynine (7-OH) concentrated at a level above 400 parts per million on a dry weight basis. This designation does not apply to mitragynine.

A kratom processor or kratom retailer shall not:
(1) Distribute, dispense, sell, or make available for sale any kratom, kratom extract, or
kratom product; or
(2) Prepare, manufacture, distribute, dispense, sell, or make available for sale any
kratom, kratom extract, or kratom product.

(9) (a) "Controlled substance analogue," except as provided in paragraph (b) of this
subsection, means a substance:
1.
The chemical structure of which is substantially similar to the structure
of a controlled substance in Schedule I or II; and
2.
Which has a stimulant, depressant, or hallucinogenic effect on the
central nervous system that is substantially similar to or greater than the
stimulant, depressant, or hallucinogenic effect on the central nervous
system of a controlled substance in Schedule I or II; or
3.
With respect to a particular person, which such person represents or
intends to have a stimulant, depressant, or hallucinogenic effect on the
central nervous system that is substantially similar to or greater than the
stimulant, depressant, or hallucinogenic effect on the central nervous
system of a controlled substance in Schedule I or II.

Instrument

KY KCPA - age 21, 2% 7-OH cap, synthetic ban (kratom leaf/product track)

Source

https://apps.legislature.ky.gov/law/acts/24RS/documents/0044.pdf

Retrieved

2026-07-07

Fingerprint

f25f84cf39cddd85

SECTION 1 (KRS 217.2201 defs): "Kratom" means any part of the plant Mitragyna speciosa; "Kratom extract" ... extracted and concentrated ...; "Kratom product" means a food, powder, capsule, pill, or any other product intended for oral consumption that contains any part of the leaf ... or any extract thereof ...
SECTION 2 (KRS 217.2202): A kratom processor or kratom retailer shall not: (1) Distribute, dispense, sell, or make available for sale any kratom extract or kratom product to an individual who is under twenty-one (21) years of age; or (2) Prepare, manufacture, distribute, dispense, sell, or make available for sale any kratom extract or kratom product that: (a) Is adulterated with a dangerous nonkratom substance ...; (b) Contains a poisonous or otherwise harmful nonkratom ingredient, including but not limited to any controlled substance as defined in KRS Chapter 218A; (c) Contains a level of 7-hydroxymitragynine in the alkaloid fraction that is greater than two percent (2%) of the overall alkaloid composition of the product; (d) Contains any synthetic alkaloid, including synthetic mitragynine, synthetic 7-hydroxymitragynine, or any other synthetically derived compound of the plant Mitragyna speciosa; (e) Contains levels of residual solvents higher than ... USP Chapter 467; or (f) Does not meet the labeling requirements ...